CAS: 2359650-19-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TPX-0046 REF: IN-DA020MFCCAS: 2359650-19-2 | 99% | To inquire | Mon 16 Dec 24 |
 | TPX-0046 REF: TM-T35384CAS: 2359650-19-2 | 99.07% | 154.00 €~2,130.00 € | Mon 23 Dec 24 |
Ref: IN-DA020MFC
| 1mg | 275.00 € | ||
| 2mg | 561.00 € | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
TPX-0046
CAS:2359650-19-2
TPX-0046 is a RET inhibitor designed to overcome resistance to Selpercatinib and Pralsetinib.
Formula:
C21H21FN6O3
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
424.43
Ref: TM-T35384
| 1mg | 154.00 € | ||
| 2mg | 217.00 € | ||
| 5mg | 346.00 € | ||
| 10mg | 540.00 € | ||
| 25mg | 1,143.00 € | ||
| 50mg | 1,576.00 € | ||
| 100mg | 2,130.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
